Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

3 Dec 2008 11:59

RNS Number : 4632J
ABCAM Plc
03 December 2008
 



For immediate release

3 December 2008

ABCAM PLC

("Abcam" or "the Company")

ABCAM PLC SHARE INCENTIVE PLAN 

Directors' Dealings

On 7 November 2008 Abcam announced that as a result of transactions on 6 November 2008 by the Abcam plc Share Incentive Plan -"the Plan" - (an HMRC approved all employee share purchase plan adopted by the Company's shareholders at the Company's AGM on 3 November 2008), Jonathan Milner, Jeff Iliffe and Jim Warwick, Executive Directors of the Company, had each been awarded 649 "Free shares". The beneficial ownership of these shares will pass to the Executive Directors on 6 November 2011 subject to their continued employment with Abcam plc.

The final dividend of 4.56 pence per share which was approved at the AGM was paid on 28 November 2008. Pursuant to the terms of the Plan, on 2 December 2008, the dividend paid on the "Free shares" granted to the Executive Directors as detailed above was used to purchase additional shares at 475p each to be held on behalf of the Executive Directors in the Abcam plc Share Incentive Plan. These shares are as detailed below: 

Dividend shares  purchased

No of shares held in the

Plan on 2 December 2008

Including the dividend

shares

Jeff Iliffe

6

1,273

Jonathan Milner

6

1,273

Jim Warwick

6

1,273

For further information please contact:

Abcam
+ 44 (0) 1223 696000
Jonathan Milner, Chief Executive Officer
 
Jeff Iliffe, Chief Financial Officer
www.abcam.com
 
 
 
Numis Securities
+ 44 (0) 20 7776 1500
Nominated Adviser - Michael Meade, Nick Westlake
Corporate Broking - James Black
 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Mary-Jane Johnson
 
 
 

Notes for editors:

About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 47,000 products, most of which are antibodies, from over 250 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs over 200 staff in its three operating companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFXLFBVLBEFBZ
Date   Source Headline
11th Nov 20153:17 pmRNSApplication for admission to trading
11th Nov 20157:00 amRNSAcquisition
6th Nov 20151:27 pmRNSDirector/PDMR Shareholding
5th Nov 20153:38 pmRNSResult of AGM
5th Nov 20157:00 amRNSAGM Statement
2nd Nov 20153:51 pmRNSTotal Voting Rights
27th Oct 20152:09 pmRNSDirector/PDMR Shareholding
27th Oct 20152:04 pmRNSDirector/PDMR Shareholding
15th Oct 20153:22 pmRNSNon-executive Director Remuneration
9th Oct 20154:45 pmRNSHolding(s) in Company
6th Oct 20155:02 pmRNSHolding(s) in Company
2nd Oct 20154:38 pmRNSAnnual Financial Report
1st Oct 20153:24 pmRNSTotal Voting Rights
25th Sep 20155:01 pmRNSDirector Shareholding
24th Sep 20155:13 pmRNSPDMR Shareholding
18th Sep 20154:39 pmRNSDirector/PDMR Shareholding
14th Sep 20157:00 amRNSDirectorate Changes
14th Sep 20157:00 amRNSFinal Results
9th Sep 20157:00 amRNSHZD & Abcam plc Sign License & Supply Agreement
1st Sep 20153:17 pmRNSTotal Voting Rights
14th Aug 20151:57 pmRNSBlocklisting Interim Review
23rd Jul 20157:00 amRNSPre-Close Trading Update
29th Jun 20159:24 amRNSCompany Secretary Change
1st Jun 20157:00 amRNSTotal Voting Rights
21st May 20156:10 pmRNSDirector Declaration
1st May 20151:40 pmRNSDirector's Dealings: LTIP
1st May 201512:46 pmRNSTotal Voting Rights
1st Apr 201511:49 amRNSTotal Voting Rights
31st Mar 20154:20 pmRNSHolding(s) in Company
27th Mar 20157:15 amRNSDirector Shareholding
27th Mar 20157:11 amRNSResults of Placing
26th Mar 20154:52 pmRNSProposed Placing
19th Mar 201510:00 amRNSPosting of half-yearly report
9th Mar 20157:00 amRNSHalf Yearly Report
11th Feb 20152:20 pmRNSNotice of Interim Results
6th Feb 20159:31 amRNSBlocklisting Interim Review
23rd Jan 20154:32 pmRNSCompletion of Tender Offer
21st Jan 20157:02 amRNSAcquisition
21st Jan 20157:00 amRNSHalf Year Trading Update
7th Jan 201510:38 amRNSChange of Adviser
12th Dec 20147:00 amRNSBoard Appointment
1st Dec 20149:03 amRNSTotal Voting Rights
7th Nov 201411:45 amRNSHolding(s) in Company
6th Nov 20146:07 pmRNSHolding(s) in Company
5th Nov 20144:23 pmRNSDirectors' dealings: Deferred Share Award
5th Nov 20144:20 pmRNSDirectors' Dealings: LTIP
5th Nov 20144:17 pmRNSDirector's Remuneration Disclosure
5th Nov 201410:43 amRNSDirector's Dealings
4th Nov 20148:37 amRNSDirector's Dealings
3rd Nov 20142:07 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.